TPG Capital has led an $80 million Series D extension for Zenoti, an India-founded and US-headquartered software provider for the spa and wellness industry.
The US International Development Finance Corporation (DFC) – formerly the Overseas Private Investment Corporation (OPIC) – has made commitments to funds being raised by Southeast Asia-focused Openspace Ventures and India’s Chiratae Ventures.
The Blackstone Group has agreed to acquire International Data Group (IDG) from China Oceanwide Holdings for an enterprise valuation of $1.3 billion.
TA Associates, a global growth-oriented investor with a presence in Asia, has closed its 14th flagship fund at the hard cap of $12.5 billion.
With big pharma scaling back early-stage discovery, CBC Group is keen to incubate biotech start-ups developing drugs from scratch. NiKang Therapeutics is the first to secure wider investor attention
SoftBank Vision Fund 2 has led a $250 million round for Zeta, an Indian-founded and now US-headquartered banking software-as-a-service (SaaS) provider, at a valuation of $1.4 billion.
Korean GP Centroid Investment Partners is tapping local investors to participate in a KRW1 trillion ($886 million) equity pool in support of its $1.7 billion acquisition of US golf club manufacturer TaylorMade.
Novo Holdings, which manages the wealth of Denmark’s Novo Nordisk Foundation, has led a $125 million Series C round for Hummingbird Bioscience, a Singapore and US-based drug developer.
Panacea Venture, a China-focused early-stage healthcare investor, has teamed up with Michael Dell’s family office to raise $200 million for a special purpose acquisition company (SPAC).
David Swensen, head of the Yale University endowment who pioneered a new approach to institutional investment management, has died aged 67 following a long battle with cancer.
In the past few months, B Capital Group has closed a late-stage fund, entered China, and moved forward with a seed-stage vehicle. Co-founder Raj Ganguly explains the firm’s thinking
Sapphire Ventures, Tiger Global Management, and Insight Venture Partners have led a $125 million Series G round for Chargebee, an India-founded and US-headquartered enterprise services business.
TuSimple, a China and US-based developer of autonomous driving technology for trucks, traded flat on debut following a $1.35 billion IPO at a market capitalization of $8.5 billion.
Partners Group is set to generate a 5x return on the sale of its 45% stake in GlobalLogic to Hitachi as momentum in corporate digital transformation makes the IT services player a hot commodity
Partners Group and Canada Pension Plain Investment Board (CPPIB) are exiting a combined 90% stake in US-headquartered GlobalLogic to Japan’s Hitachi at an equity valuation of $8.5 billion.
TuSimple, a China and US-based developer of autonomous driving technology for trucks, has filed for a US IPO. Its backers include CDH Investments, Zhiping Capital, Sina Corporation, and Hong Kong hedge fund Composite Capital.
Invesco has led a $155 million Series C round for China-focused infectious diseases drug developer Brii Biosciences.
Connect Biopharma, a China-headquartered drug developer specializing in treatments for T cell-driven inflammatory diseases, gained 8.8% on debut following a $191.3 million US IPO.
A more than 100% year-on-year increase in deal volume saw Asia Pacific overtake North America to become the most active global private equity healthcare market for the first time in 2020.
SIP Global Partners, a US and Japan-headquartered VC firm, has reached a first close of $75 million on its debut cross-border fund. The target is $150 million.
Rocket Lab, a US-based space technology company that operates primarily in New Zealand, as agreed to merge with a special purpose acquisition company (SPAC) at an enterprise valuation of $4.1 billion.
The global SPAC craze is percolating into Asia, with private equity firms among the sponsors. LPs aren’t necessarily comfortable with the development, but there’s only so much they can do about it
B Capital Group, a US-based venture capital firm with a presence in Singapore and a significant Asia portfolio, is looking to raise $300 million for a special purpose acquisition company (SPAC).
CITIC Capital Partners has exited US-based dental business DDS Lab – the private equity firm’s first acquisition in the US as a lead investor – to RoundTable Healthcare Partners for an undisclosed sum.